Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$697,937
in 4 filings, $698K under 10b5-1 plans

Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-22 Hopkinson Craig C. EVP R&D, Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +196,484 196,484
2021-02-22 Hopkinson Craig C. EVP R&D, Chief Medical Officer Grant or award · Restricted Stock Unit Award +48,151 48,151
2021-02-22 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Grant or award · Employee Stock Option (Right to Buy) +118,925 118,925
2021-02-22 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Grant or award · Restricted Stock Unit Award +29,144 29,144
2021-02-22 Brown Iain Michael SVP, Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +113,754 113,754
2021-02-22 Brown Iain Michael SVP, Chief Financial Officer Grant or award · Restricted Stock Unit Award +27,877 27,877
2021-02-21 POPS RICHARD F Director and CEO, Alkermes plc Exercise or conversion +32,400 806,426
2021-02-21 POPS RICHARD F Director and CEO, Alkermes plc Shares withheld for taxes −14,386 $19.58 $282K 792,040
2021-02-21 POPS RICHARD F Director and CEO, Alkermes plc Exercise or conversion · Restricted Stock Unit Award −32,400 64,800
2021-02-21 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Shares withheld for taxes −2,587 $19.58 $51K 216,781
2021-02-21 Jackson Blair Curtis EVP, Chief Operating Officer Exercise or conversion +4,800 69,566
2021-02-21 Jackson Blair Curtis EVP, Chief Operating Officer Shares withheld for taxes −1,412 $19.58 $28K 68,154
2021-02-21 Jackson Blair Curtis EVP, Chief Operating Officer Exercise or conversion · Restricted Stock Unit Award −4,800 9,600
2021-02-21 Hopkinson Craig C. EVP R&D, Chief Medical Officer Exercise or conversion +6,875 30,942
2021-02-21 Hopkinson Craig C. EVP R&D, Chief Medical Officer Shares withheld for taxes −2,022 $19.58 $40K 28,920
2021-02-21 Hopkinson Craig C. EVP R&D, Chief Medical Officer Exercise or conversion · Restricted Stock Unit Award −6,875 13,750
2021-02-21 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Exercise or conversion +6,875 76,619
2021-02-21 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Shares withheld for taxes −2,022 $19.58 $40K 74,597
2021-02-21 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Exercise or conversion · Restricted Stock Unit Award −6,875 13,750
2021-02-21 Brown Iain Michael SVP, Chief Financial Officer Exercise or conversion +4,800 49,774

Page 66 of 75 · 1,492 trades